Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Sotomayor 'Clearly Belongs' On Supreme Court, NYT Editorial Says
Despite "the flimsy arguments" that some Republicans on the Senate Judiciary Committee made for opposing the confirmation of Supreme Court nominee Sonia Sotomayor, she "clearly belongs on the court," a New York Times editorial states. Although Sotomayor sometimes avoided "forthright answers on important legal issues" during the confirmation hearings, she consistently "showed an impressive command of the law," according to the editorial.Claims that Sotomayor would not be able to resist "judicial activism" and that she would be "overly influenced by "personal preferences"" if she were to serve on the court are "strikingly weak," the editorial states. It continues, "Some Republicans may be wary of opposing Judge Sotomayor because she would be the first Hispanic justice, and they are reluctant to alienate a large voting bloc," but "[t]here is no need for political calculations." According to the editorial, "Senators should support her because she is eminently qualified."The editorial states, "We hope the vote in the full Senate for Judge Sotomayor will be overwhelming and the rhetoric more high-minded" (New York Times, 8/2).

David Cameron Makes Autism Pledge And Backs Autism Bill
Commenting on today"s speech by Conservative Party Leader Rt
News of the day
Latest Erbitux Data On Metastatic Colorectal Cancer Presented At WCGIC Underline Benefits In Patients With KRAS Wild-Type Tumors
Latest Erbitux® (cetuximab) data presented today at the World Congress on Gastrointestinal Cancer (WCGIC) reinforce the value of the targeted therapy in the treatment of metastatic colorectal cancer (mCRC) patients with KRAS wild-type (wt) tumors. Results from the CRYSTALa and CELIMb trials have provided further evidence that KRAS mutation status is the current accepted standard predictive biomarker for Erbitux efficacy in patients with mCRC. In addition, new data have shown that the rash associated with Erbitux therapy can be effectively treated with a cream containing vitamin K.
Public Health

New Way To Enhance Stem Cells To Stimulate Muscle Regeneration Discovered By Ottawa Scientists

Scientists at the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa have discovered a powerful new way to stimulate muscle regeneration, paving the way for new treatments for debilitating conditions such as muscular dystrophy. The research, to be published in the June 5 issue of Cell Stem Cell, shows for the first time that a protein called Wnt7a increases the number of stem cells in muscle tissue, leading to accelerated growth and repair of skeletal muscle. "This discovery shows us that by targeting stem cells to boost their numbers, we can improve the body"s ability to repair muscle tissue," said senior author Dr. Michael Rudnicki. Dr. Rudnicki is the Scientific Director of Canada"s Stem Cell Network and a Senior Scientist at OHRI and Director of OHRI"s Sprott Centre for Stem Cell Research, as well as a Professor of Medicine at the University of Ottawa. Stem cells give rise to every tissue and organ in the body. Satellite stem cells are specialized muscle stem cells that live in adult skeletal muscle tissue and have the ability to both replicate and differentiate into various types of muscle cells. Dr. Rudnicki"s team found that the Wnt7a protein, when introduced into mouse muscle tissue, significantly increased the population of these satellite stem cells and fueled the regeneration process, creating bigger and stronger muscles. Muscle tissue mass was increased by nearly 20 per cent in the study. "Our findings point the way to the development of new therapeutic treatment for muscular diseases such as muscular dystrophy, sarcopenia and muscle wasting conditions resulting from extended hospital stays and surgeries," said Dr. Rudnicki. This project was funded by the Canadian Institutes of Health Research, the Muscular Dystrophy Association, the National Institutes of Health, the Howard Hughes Medical Institute, Canada"s Stem Cell Network and the Canada Research Chairs Program. Jennifer Paterson Ottawa Hospital Research Institute


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009